ConductScience.org, home

Paper51647

Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.

Nind AP and 4 others. Br J Cancer, 1975. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Papers, record 51647. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/51647

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.
PubMed
Journal
Br J Cancer
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2019-05-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nind APA P
2Matthews NN
3Pihl EAE A
4Rolland JMJ M
5Nairn RCR C

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BloodMajor topic
Colonic NeoplasmsMajor topic
LymphocytesMajor topic
Adult
Antigen-Antibody Complex
Antigens, Neoplasm
Cytotoxicity Tests, Immunologic
Epitopes
Female
Humans
Immune Adherence Reaction
In Vitro Techniques
Male
T-Lymphocytes

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14114496Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.J Exp Med1972https://conductscience.org/library/papers/4114496PubMed
24546321Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.Int J Cancer1974https://conductscience.org/library/papers/4546321PubMed
34581078Lymphocyte anergy in patients with carcinoma.Br J Cancer1973https://conductscience.org/library/papers/4581078PubMed
44591169Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.J Exp Med1974https://conductscience.org/library/papers/4591169PubMed
54614776Electron microscope observations of the in vitro interaction between human leucocytes and cancer cells.Aust J Exp Biol Med Sci1974https://conductscience.org/library/papers/4614776PubMed
65492276Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors.Int Arch Allergy Appl Immunol1970https://conductscience.org/library/papers/5492276PubMed
74735112A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.Br J Cancer1973https://conductscience.org/library/papers/4735112PubMed
84790696Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.Int J Cancer1973https://conductscience.org/library/papers/4790696PubMed
94790711Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.Int J Cancer1973https://conductscience.org/library/papers/4790711PubMed
104943033Immunological reactivity in patients with carcinoma of colon.Br Med J1971https://conductscience.org/library/papers/4943033PubMed
115437620A microassay for cell-mediated immunity.Transplantation1970https://conductscience.org/library/papers/5437620PubMed
124709269The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.J Exp Med1973https://conductscience.org/library/papers/4709269PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
7366126[Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].Klin Wochenschr1980https://conductscience.org/library/papers/7366126PubMed
1174874Colonic carcinoma: clinicopathological correlation with immunoreactivity.Br Med J1975https://conductscience.org/library/papers/1174874PubMed
773397Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.Br J Cancer1976https://conductscience.org/library/papers/773397PubMed
316708Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.Br J Cancer1979https://conductscience.org/library/papers/316708PubMed
226300An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract.Clin Exp Immunol1979https://conductscience.org/library/papers/226300PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/51647

GET https://conductscience.org/api/papers/v1/51647/authors